Health Canada inspection
Lilly Del Caribe Inc.: Health Canada inspection of Feb 13, 2026
Health Canada · GMP · rating C
Key facts
| Establishment | Lilly Del Caribe Inc. |
|---|---|
| City | Carolina |
| Province | PR |
| Country | United States |
| Program | GMP |
| Start date | Feb 9, 2026 |
| End date | Feb 13, 2026 |
| Rating | C |
| Rating description | Compliant |
| Licence number | Not applicable |
At a glance
- 1–9 Observations cited
- 1–9 Inspections of this establishment
- No Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.